132 related articles for article (PubMed ID: 2104762)
1. Activation of lymphocytes induced by recombinant human granulocyte-macrophage colony-stimulating factor in patients with malignant lymphoma.
Ho AD; Haas R; Wulf G; Knauf W; Ehrhardt R; Heilig B; Körbling M; Schulz G; Hunstein W
Blood; 1990 Jan; 75(1):203-12. PubMed ID: 2104762
[TBL] [Abstract][Full Text] [Related]
2. Mitoxantrone/high-dose Ara-C and recombinant human GM-CSF in the treatment of refractory non-Hodgkin's lymphoma. A pilot study.
Ho AD; Del Valle F; Engelhard M; Hiddemann W; Rückle H; Schlimok G; Haas R; Thiel E; Andreesen R; Fiedler W
Cancer; 1990 Aug; 66(3):423-30. PubMed ID: 2194641
[TBL] [Abstract][Full Text] [Related]
3. Sequential studies on the role of mitoxantrone, high-dose cytarabine, and recombinant human granulocyte-macrophage colony-stimulating factor in the treatment of refractory non-Hodgkin's lymphoma.
Ho AD; Del Valle F; Haas R; Engelhard M; Hiddemann W; Rückle H; Schlimok G; Thiel E; Andreesen R; Fiedler W
Semin Oncol; 1990 Dec; 17(6 Suppl 10):14-8; discussion 18-9. PubMed ID: 2259918
[TBL] [Abstract][Full Text] [Related]
4. Recombinant human granulocyte-macrophage colony-stimulating factor in patients with myelodysplastic syndromes--a phase I/II trial.
Ganser A; Völkers B; Greher J; Ottmann OG; Walther F; Becher R; Bergmann L; Schulz G; Hoelzer D
Blood; 1989 Jan; 73(1):31-7. PubMed ID: 2642714
[TBL] [Abstract][Full Text] [Related]
5. In vitro and in vivo activity of human recombinant granulocyte-macrophage colony-stimulating factor in dogs.
Mayer P; Werner FJ; Lam C; Besemer J
Exp Hematol; 1990 Oct; 18(9):1026-33. PubMed ID: 2168838
[TBL] [Abstract][Full Text] [Related]
6. Recombinant human granulocyte-macrophage colony-stimulating factor reduces hematologic toxicity and widens clinical applicability of high-dose cyclophosphamide treatment in breast cancer and non-Hodgkin's lymphoma.
Gianni AM; Bregni M; Siena S; Orazi A; Stern AC; Gandola L; Bonadonna G
J Clin Oncol; 1990 May; 8(5):768-78. PubMed ID: 2185337
[TBL] [Abstract][Full Text] [Related]
7. Recombinant human granulocyte-macrophage colony-stimulating factor (rhGM-CSF) subsequent to chemotherapy improves collection of blood stem cells for autografting in patients not eligible for bone marrow harvest.
Haas R; Hohaus S; Egerer G; Ehrhardt R; Witt B; Hunstein W
Bone Marrow Transplant; 1992 Jun; 9(6):459-65. PubMed ID: 1352717
[TBL] [Abstract][Full Text] [Related]
8. Detection of soluble interleukin-2 receptor and interleukin-10 in the serum of patients with aggressive non-Hodgkin's lymphoma. Identification of a subset at high risk of treatment failure.
Stasi R; Zinzani L; Galieni P; Lauta VM; Damasio E; Dispensa E; Dammacco F; Tura S; Papa G
Cancer; 1994 Sep; 74(6):1792-800. PubMed ID: 8082082
[TBL] [Abstract][Full Text] [Related]
9. Simultaneous administration of granulocyte-macrophage colony-stimulating factor and cytosine arabinoside for the treatment of relapsed acute myeloid leukemia.
Cannistra SA; DiCarlo J; Groshek P; Kanakura Y; Berg D; Mayer RJ; Griffin JD
Leukemia; 1991 Mar; 5(3):230-8. PubMed ID: 1826536
[TBL] [Abstract][Full Text] [Related]
10. Recombinant human granulocyte macrophage colony stimulating factor (rhGM-CSF) following autologous marrow transplantation in man.
Appelbaum FR; Nemunaitis J
Behring Inst Mitt; 1988 Aug; (83):145-8. PubMed ID: 3071330
[TBL] [Abstract][Full Text] [Related]
11. Recombinant human interleukin-3 and recombinant human granulocyte-macrophage colony-stimulating factor administered in vivo after high-dose cyclophosphamide cancer chemotherapy: effect on hematopoiesis and microenvironment in human bone marrow.
Orazi A; Cattoretti G; Schiró R; Siena S; Bregni M; Di Nicola M; Gianni AM
Blood; 1992 May; 79(10):2610-9. PubMed ID: 1586713
[TBL] [Abstract][Full Text] [Related]
12. Long-term follow-up of a phase III study of recombinant human granulocyte-macrophage colony-stimulating factor after autologous bone marrow transplantation for lymphoid malignancies.
Rabinowe SN; Neuberg D; Bierman PJ; Vose JM; Nemunaitis J; Singer JW; Freedman AS; Mauch P; Demetri G; Onetto N
Blood; 1993 Apr; 81(7):1903-8. PubMed ID: 8461475
[TBL] [Abstract][Full Text] [Related]
13. Stimulation of canine hematopoiesis by recombinant human granulocyte-macrophage colony-stimulating factor.
Schuening FG; Storb R; Goehle S; Nash R; Graham TC; Appelbaum FR; Hackman R; Sandmaier BM; Urdal DL
Exp Hematol; 1989 Sep; 17(8):889-94. PubMed ID: 2670596
[TBL] [Abstract][Full Text] [Related]
14. A phase II study of continuous infusion recombinant human granulocyte-macrophage colony-stimulating factor as an adjunct to autologous bone marrow transplantation for patients with non-Hodgkin's lymphoma in first remission.
O'Day SJ; Rabinowe SN; Neuberg D; Freedman AS; Soiffer RJ; Spector NA; Robertson MJ; Anderson K; Whelan M; Pesek K
Blood; 1994 May; 83(9):2707-14. PubMed ID: 8167349
[TBL] [Abstract][Full Text] [Related]
15. Recombinant granulocyte-macrophage colony-stimulating factor after autologous bone marrow transplantation for relapsed non-Hodgkin's lymphoma: blood and bone marrow progenitor growth studies. A phase II Eastern Cooperative Oncology Group Trial.
Lazarus HM; Andersen J; Chen MG; Variakojis D; Mansour EG; Oette D; Arce CA; Oken MM; Gerson SL
Blood; 1991 Aug; 78(3):830-7. PubMed ID: 1859894
[TBL] [Abstract][Full Text] [Related]
16. Granulocyte-colony-stimulating factor induces increased serum levels of soluble interleukin 2 receptors preceding engraftment in autologous bone marrow transplantation.
Dreger P; Grelle K; Eckstein V; Suttorp M; Müller-Ruchholtz W; Löffler H; Schmitz N
Br J Haematol; 1993 Jan; 83(1):7-13. PubMed ID: 7679589
[TBL] [Abstract][Full Text] [Related]
17. Congenital neutropenia: a case study.
Daghistani D; Jimenez JJ; Toledano SR; Cirocco RE; Yunis AA
Am J Pediatr Hematol Oncol; 1990; 12(2):210-4. PubMed ID: 1696074
[TBL] [Abstract][Full Text] [Related]
18. The effect of three human recombinant hematopoietic growth factors (granulocyte-macrophage colony-stimulating factor, granulocyte colony-stimulating factor, and interleukin-3) on phagocyte oxidative activity.
Sullivan GW; Carper HT; Mandell GL
Blood; 1993 Apr; 81(7):1863-70. PubMed ID: 7681704
[TBL] [Abstract][Full Text] [Related]
19. Autologous blood progenitor cell transplantation in relapsed Hodgkin's disease--the role of haematopoietic growth factors.
Haas R; Hohaus S; Ehrhardt R; Goldschmidt H; Hunstein W
Bone Marrow Transplant; 1993; 11 Suppl 2():30-5. PubMed ID: 8101459
[TBL] [Abstract][Full Text] [Related]
20. Effect of recombinant human granulocyte-macrophage colony-stimulating factor on chemotherapy-induced myelosuppression.
Antman KS; Griffin JD; Elias A; Socinski MA; Ryan L; Cannistra SA; Oette D; Whitley M; Frei E; Schnipper LE
N Engl J Med; 1988 Sep; 319(10):593-8. PubMed ID: 3045544
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
